Show simple item record

dc.contributor.authorReece-Hoyes, John S.
dc.contributor.authorWalhout, Albertha J. M.
dc.date2022-08-11T08:10:59.000
dc.date.accessioned2022-08-23T17:27:23Z
dc.date.available2022-08-23T17:27:23Z
dc.date.issued2018-01-02
dc.date.submitted2018-02-20
dc.identifier.citation<p>Cold Spring Harb Protoc. 2018 Jan 2;2018(1):pdb.prot094920. doi: 10.1101/pdb.prot094920. <a href="https://doi.org/10.1101/pdb.prot094920">Link to article on publisher's site</a></p>
dc.identifier.issn1559-6095 (Linking)
dc.identifier.doi10.1101/pdb.prot094920
dc.identifier.pmid29295904
dc.identifier.urihttp://hdl.handle.net/20.500.14038/49849
dc.description.abstractGenerating stocks of Entry and Destination vectors for use in the Gateway recombinatorial cloning system requires transforming them into Escherichia coli strain DB3.1, where they can replicate because this strain is immune to the effects of the ccdB gene carried in the Gateway cassette. However, mutations in the ccdB gene can arise at low frequency, and these mutant plasmids will consequently allow growth of standard cloning strains of E. coli (e.g., DH5alpha). Therefore, after making new stocks of Gateway plasmids, their ability to grow in cloning strains of E. coli must be tested. This involves obtaining multiple stocks of vector, each arising from a single plasmid grown in a single DB3.1 bacterial colony, and transforming each stock into both DB3.1 and the preferred cloning strain of E. coli in a controlled fashion. Only vector stocks that effectively kill the standard cloning strain (i.e., no or few colonies are obtained after transformation) should be used in Gateway cloning reactions. The sequence can be performed in 3 d.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=29295904&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1101/pdb.prot094920
dc.subjectGenetic Phenomena
dc.subjectGenetics and Genomics
dc.subjectGenetic Structures
dc.subjectInvestigative Techniques
dc.subjectLaboratory and Basic Science Research
dc.subjectMolecular Biology
dc.subjectSystems Biology
dc.titlePropagating Gateway Vectors
dc.typeJournal Article
dc.source.journaltitleCold Spring Harbor protocols
dc.source.volume2018
dc.source.issue1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/sysbio_pubs/122
dc.identifier.contextkey11595675
html.description.abstract<p>Generating stocks of Entry and Destination vectors for use in the Gateway recombinatorial cloning system requires transforming them into Escherichia coli strain DB3.1, where they can replicate because this strain is immune to the effects of the ccdB gene carried in the Gateway cassette. However, mutations in the ccdB gene can arise at low frequency, and these mutant plasmids will consequently allow growth of standard cloning strains of E. coli (e.g., DH5alpha). Therefore, after making new stocks of Gateway plasmids, their ability to grow in cloning strains of E. coli must be tested. This involves obtaining multiple stocks of vector, each arising from a single plasmid grown in a single DB3.1 bacterial colony, and transforming each stock into both DB3.1 and the preferred cloning strain of E. coli in a controlled fashion. Only vector stocks that effectively kill the standard cloning strain (i.e., no or few colonies are obtained after transformation) should be used in Gateway cloning reactions. The sequence can be performed in 3 d.</p>
dc.identifier.submissionpathsysbio_pubs/122
dc.contributor.departmentProgram in Molecular Medicine
dc.contributor.departmentProgram in Systems Biology
dc.source.pagespdb.prot094920


This item appears in the following Collection(s)

Show simple item record